Last reviewed · How we verify
Sodium monoflurophosphate
At a glance
| Generic name | Sodium monoflurophosphate |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion (PHASE2)
- Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sodium monoflurophosphate CI brief — competitive landscape report
- Sodium monoflurophosphate updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI